Gsa Capital Partners LLP Vertex Pharmaceuticals Inc Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$392.81 - $485.53 $256,112 - $316,565	652 New	652 $306,000
Q2 2022 Aug 09, 2022	SELL	$234.96 - $292.55 $409,535 - $509,914	-1,743 Reduced 51.07%	1,670 $471,000
Q1 2022 May 11, 2022	BUY	$221.42 - $260.97 $409,405 - $482,533	1,849 Added 118.22%	3,413 $891,000
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $158,423 - $199,987	-895 Reduced 36.4%	1,564 $343,000
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $248,867 - $278,502	1,372 Added 126.22%	2,459 $446,000
Q2 2021 Aug 05, 2021	BUY	$187.49 - $221.1 $203,801 - $240,335	1,087 New	1,087 $219,000
Q4 2020 Feb 03, 2021	SELL	$207.01 - $276.09 $214,669 - $286,305	-1,037 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$255.65 - $303.1 $265,109 - $314,314	1,037 New	1,037 $282,000
Q2 2020 Aug 11, 2020	SELL	$225.48 - $295.8 $335,965 - $440,742	-1,490 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$199.77 - $247.81 $215,152 - $266,891	-1,077 Reduced 41.96%	1,490 $355,000
Q4 2019 Feb 12, 2020	SELL	$166.71 - $223.91 $1.18 Million - $1.59 Million	-7,105 Reduced 73.46%	2,567 $562,000
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $1.24 Million - $1.4 Million	7,479 Added 341.04%	9,672 $1.64 Million
Q2 2019 Aug 06, 2019	SELL	$164.61 - $190.37 $329,549 - $381,120	-2,002 Reduced 47.72%	2,193 $402,000
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $68,275 - $81,189	-417 Reduced 9.04%	4,195 $772,000
Q4 2018 Feb 12, 2019	SELL	$151.91 - $192.21 $1.18 Million - $1.49 Million	-7,743 Reduced 62.67%	4,612 $764,000
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $1.52 Million - $1.75 Million	-9,087 Reduced 42.38%	12,355 $2.38 Million
Q2 2018 Aug 09, 2018	SELL	$145.72 - $169.96 $1.77 Million - $2.06 Million	-12,129 Reduced 36.13%	21,442 $3.64 Million
Q1 2018 May 11, 2018	BUY	$151.6 - $177.13 $1.1 Million - $1.29 Million	7,264 Added 27.61%	33,571 $5.47 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $1.26 Million - $1.43 Million	9,194 Added 53.73%	26,307 $3.94 Million
Q3 2017 Nov 20, 2017	BUY	$148.13 - $162.24 $2.53 Million - $2.78 Million	17,113	17,113 $2.6 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.5 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.9 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.49 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.18 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account